The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.

Injecting immunostimulants directly into the tumor is not a new strategy to stimulate the immune system, but the approach has seen a surge of interest in recent years.

Comparing the cells of cancer patients who did and did not respond to the immunotherapy could reveal biomarkers to predict who should receive it in the first place.

Those with two copies of the Δ32 allele in the CCR5 gene are 21 percent more likely to die by age 76, although it’s not clear why.

An experiment delves into how the microbiome shapes immunity.

A rogue hybrid lymphocyte, bearing characteristics of both B and T cells, may play a role in driving autoimmunity in the disease, although the mechanism is far from clear.

A video captures T cells learning to recognize cells from the body that shouldn’t be attacked.

A new study reveals an unexpected role for the immune cells and a previously unknown mechanism for the wasting syndrome.

An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.